Azienda Ospedaliera Universitaria Meyer IRCCS

3 trials 1 recruiting Academic / non-commercial Merged from 2 name variants

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

1 Countries active

10 Unique IMPs

100% Results reported

Phase II

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Epilepsy 1 Medulloblastoma 1 Glioblastoma 1

Top IMPs

All trials

3 total

Clinical study to assess the efficacy and safety of Cannabidiol in children and young adults with rare disease-associated severe epilepsy Recruiting

2023-503709-12-00 Phase II 1 country CANNABIDIOL
An interventional, open-label, Phase II study, to evaluate safety and efficacy of standard and high-dose chemotherapy associated with cranio… Ended

2024-518964-11-01 Phase II 1 country
Clinical trial to evaluate the effects of chemotherapy with anthracycline, after radiotherapy, in a group of pediatric and young adult patie… Ended

2024-519135-41-00 Phase II 1 country

Showing 1–3 of 3 trials

← All sponsors A–Z